GMB-475 induced the degradation of the target protein in CML stem cell populations also, but without causing marked apoptosis, further confirming that CML stem cells’ survival is not dependent on BCR-ABL (195). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.